Results 51 to 60 of about 14,040 (225)

Toward Precision Cancer Immunotherapy. [PDF]

open access: yesAdv Sci (Weinh)
Advanced Science, Volume 13, Issue 35, 24 June 2026.
Tang S, Zhao JJ, Wong AH.
europepmc   +2 more sources

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin

open access: yesLipids in Health and Disease, 2011
Background Fibrates have been reported to cause paradoxical decreases in HDL-C in certain patients. Design and methods This post-hoc analysis explored the frequency/magnitude of HDL-C reductions in a pooled database of mixed dyslipidemic patients (LDL-C ...
Farnier Michel   +4 more
doaj   +1 more source

Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease

open access: yesРациональная фармакотерапия в кардиологии, 2020
Aim. To reveal the statistically significant determinants of the coronary artery (CA) stenosis ≥70% in patients with chronic stable CA disease receiving drug therapy.Material and methods.
O. A. Koshelskaya   +6 more
doaj   +1 more source

Uncovering Coenzyme Q10‐Related Genetic Determinants of Statin‐Associated Muscle Symptoms: Evidence from the UK Biobank and the All of Us Research Program

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Statin‐associated muscle symptoms (SAMS) are frequent adverse effects of statin therapy and have been hypothesized to result from impaired coenzyme Q10 (CoQ10) biosynthesis. Although genetic determinants of CoQ10 levels have been reported, genome‐wide association studies (GWASs) conducted specifically in statin users are lacking. Moreover, direct CoQ10
Da Hoon Lee   +6 more
wiley   +1 more source

Diagonal fibrations are pointwise fibrations

open access: yes, 2007
to be published in "Journal of Homotopy and Related Structures"
Cegarra, A. M., Remedios, J.
openaire   +3 more sources

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

open access: yesCardiovascular Diabetology, 2004
Background Hypertriglyceridemia in combination with low HDL cholesterol levels is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of ciprofibrate for the treatment of this form of dyslipidemia and to identify factors ...
Medel Octavio   +25 more
doaj   +1 more source

Food‐grade proteins, lipids, and fibers as potential tools to ameliorate cardiovascular disorders: A review

open access: yesFood Biomacromolecules, EarlyView.
Abstract Cardiovascular diseases (CVDs) remain the leading cause of global mortality, necessitating effective preventive and adjunct therapeutic strategies beyond conventional pharmacological interventions. Although previous reviews have focused on individual nutrients or dietary patterns, this review provides a mechanism‐based, integrative perspective
Sridevi Shanmugam   +7 more
wiley   +1 more source

Lefschetz Fibrations and real Lefschetz fibrations

open access: yesWinter Braids Lecture Notes, 2015
This note is based on the lectures that I have given during the winter school Winter Braids IV, School on algebraic and topological aspects of braid groups held in Dijon on 10 - 13 February 2014.
openaire   +1 more source

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

open access: yes, 2006
To assess the impact of lipid lowering treatment with fibrates on cardiovascular endpoints in patients with type 2 diabetes ...
Allemann, Sabin   +4 more
core   +1 more source

Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review

open access: yesCardiovascular Diabetology, 2005
Background The importance of low high-density lipoprotein cholesterol (HDL-C), elevated non HDL-C (as part of the metabolic syndrome, prediabetes, and type 2 diabetes mellitus), and an isolated low HDL-C is rapidly emerging. The antiatherosclerotic roles
Tyagi Suresh C, Hayden Melvin R
doaj   +1 more source

Home - About - Disclaimer - Privacy